Note 10 - Subsequent Events

3 Months Ended

Mar. 31, 2015

Notes to Financial Statements

Subsequent Events [Text Block]

10 . Subsequent events

In April 2015, the T-SPOT.

CMV

test received a CE Mark approval in Europe. This test measures the strength of a patient's cellular immune response to CMV.

In April 2015, the Company entered into a First Amendment to Distributorship Agreement (the “Amendment”) with Fosun Long March Medical Science Co. Ltd. and Shanghai Xin Chang Medical Device Co. Ltd. (collectively the “Distributors”). The Amendment amends the Distributorship Agreement between the parties dated October 8, 2013, pursuant to which the Distributors purchase T-SPOT.

TB

test kits from the Company for distribution in China (the “Agreement”). In accordance with the terms of the Amendment, the Company will provide the Distributors with a certain quantity of T-SPOT.

TB

test kits at no charge for use in the Distributors’ discount programs, subject to the achievement by the Distributors of certain minimum purchase requirements.